Failure of rivaroxaban to prevent thrombosis in four patients with anti-phospholipid syndrome

Virginie Dufrost¹, Jessie Risse^{1

2}, Stéphane Kirchner³, Stéphane Zuily^{1

2}, Denis Wahl^{1

2}

Affiliations

¹ CHRU de Nancy, Vascular Medicine Division and Regional Competence Center for Rare Vascular and Systemic Autoimmune Diseases.
² Inserm UMR_S 1116 School of Medicine, Lorraine University.
³ Department of Pathology, Pathology Center Emile Gallé, Nancy, France.

Case Reports

Virginie Dufrost et al. Rheumatology (Oxford). 2017.

. 2017 Aug 1;56(8):1433-1434.

doi: 10.1093/rheumatology/kex086.

Virginie Dufrost¹, Jessie Risse^{1

2}, Stéphane Kirchner³, Stéphane Zuily^{1

2}, Denis Wahl^{1

2}

¹ CHRU de Nancy, Vascular Medicine Division and Regional Competence Center for Rare Vascular and Systemic Autoimmune Diseases.
² Inserm UMR_S 1116 School of Medicine, Lorraine University.
³ Department of Pathology, Pathology Center Emile Gallé, Nancy, France.

No abstract available

Comment in

Comment on: Failure of rivaroxaban to prevent thrombosis in four patients with anti-phospholipid syndrome: reply.
Dufrost V, Risse J, Wahl D, Zuily S. Dufrost V, et al. Rheumatology (Oxford). 2018 May 1;57(5):939-940. doi: 10.1093/rheumatology/kex464. Rheumatology (Oxford). 2018. PMID: 29373692 No abstract available.
Comment on: Failure of rivaroxaban to prevent thrombosis in four patients with anti-phospholipid syndrome.
Scanvion Q, Morell-Dubois S, Yelnik CM, Bene J, Gautier S, Lambert M. Scanvion Q, et al. Rheumatology (Oxford). 2018 May 1;57(5):938-939. doi: 10.1093/rheumatology/kex463. Rheumatology (Oxford). 2018. PMID: 29373704 No abstract available.